The Centers for Disease Control and Prevention today revealed the comparative effectiveness of the three Food and Drug Administration-authorized COVID-19 vaccines, with Moderna’s vaccine deemed most effective at preventing hospitalizations. Moderna’s vaccine was 93% effective during a five-month period in preventing hospitalizations among adults without immunocompromised conditions in the U.S., compared to Pfizer (88%) and Johnson & Johnson (71%). Despite the rankings, the study authors maintained that all three vaccines provide “substantial” protection against COVID-19 hospitalization.

Related News Articles

Headline
The Occupational Safety and Health Administration today announced a 60-day extension of the comment period on its proposed rule to remove the remaining…
Headline
COVID-19 infections are growing or likely growing in 45 states and not changing in five states, according to the latest data from the Centers for Disease…
Headline
The Food and Drug Administration July 15 announced a recall by Sandoz on certain lots of cefazolin, due to the lots being mislabeled as penicillin G potassium…
Headline
 The Food and Drug Administration July 10 approved Moderna’s Spikevax COVID-19 vaccine for children under 12 with at least one underlying condition that…
Headline
The Occupational Safety and Health Administration June 30 released a proposed rule to remove what remains of its emergency temporary standard for occupational…
Headline
Department of Health and Human Services Secretary Robert F. Kennedy Jr. May 27 announced in a post on X that the Centers for Disease Control and Prevention…